UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.

NCT05148377 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemodialysis Complication

Interventions

DRUG: Liquaemin
DRUG: Heptar

Sponsor

Eurofarma Laboratorios S.A.